Kurt Swogger, CEO, BioPact Ventures, Austin, TX, talks on the development, manufacturing process, and advantages of BioPact’s Medical Grade Molecular Rebar (MGMR™️) technology, a carbon nanotube designed to deliver a wide range of therapeutics to cells. These nanotubes are remarkably safe and can easily penetrate cells without causing damage. MGMR™️ can be loaded with a variety of cargos depending on the surfactant on the surface of the tube. In addition, MGMR™️’s simple manufacturing process results in faster delivery of products to patients than with viral vectors. Mr Swogger explains that BioPact is currently looking for partners to develop this technology. This interview took place at Advanced Therapies Week 2022.